- 全部删除
您的购物车当前为空
CH-223191 是一种特异性有效的芳烃受体 (AhR) 拮抗剂,抑制 TCDD 诱导的荧光素酶活性的 IC50值为 0.03 μM。CH-223191可用于肿瘤免疫治疗、细胞毒性研究、干细胞研究、炎症研究、神经保护。


为众多的药物研发团队赋能,
让新药发现更简单!
CH-223191 是一种特异性有效的芳烃受体 (AhR) 拮抗剂,抑制 TCDD 诱导的荧光素酶活性的 IC50值为 0.03 μM。CH-223191可用于肿瘤免疫治疗、细胞毒性研究、干细胞研究、炎症研究、神经保护。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 218 | In stock | |
| 5 mg | ¥ 483 | In stock | |
| 10 mg | ¥ 842 | In stock | |
| 25 mg | ¥ 1,550 | In stock | |
| 50 mg | ¥ 2,630 | In stock | |
| 100 mg | ¥ 3,920 | In stock | |
| 200 mg | ¥ 5,690 | In stock | |
| 500 mg | ¥ 8,760 | In stock |
CH-223191 相关产品
| 产品描述 | CH-223191 is a specific and effective aromatic hydrocarbon receptor (AhR) antagonist, and its IC50 value for inhibiting luciferase activity induced by TCDD is 0.03 μM. CH-223191 can be used in tumor immunotherapy, cytotoxicity research, stem cell research, inflammation research and neuroprotection. |
| 靶点活性 | AhR:30 nM |
| 体外活性 | 方法:HepG2 cells用CH-223191(0.1-10 μM)处理1小时,使用Western Blot方法检测蛋白水平。 |
| 体内活性 | 方法:为研究CH-223191 预防2,3,7,8-TCDD诱导的毒性作用,将CH-223191(10 mg/kg)腹腔注射给雄性ICR小鼠,每天一次,持续25天。 |
| 别名 | CH 223191 |
| 分子量 | 333.39 |
| 分子式 | C19H19N5O |
| CAS No. | 301326-22-7 |
| Smiles | Cc1ccccc1\N=N\c1ccc(NC(=O)c2ccnn2C)c(C)c1 |
| 密度 | 1.20 g/cm3 (Predicted) |
| 颜色 | Orange |
| 物理性状 | Solid |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||||||||||||
| 溶解度信息 | Ethanol: 3.3 mg/mL (9.9 mM), Sonication is recommended. DMSO: 127 mg/mL (380.94 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||||||||||||||||||||||
Ethanol/DMSO
DMSO
| |||||||||||||||||||||||||||||||||||||||||
评论内容